Club
Clubbing
Clubbing refers to the bulbous enlargement of the ends of one or more fingers or toes. It is a physical sign that can be associated with a variety of underlying medical conditions, particularly those affecting the heart and lungs.
History
The phenomenon of clubbing was first described by Hippocrates, the ancient Greek physician, and is sometimes referred to as "Hippocratic fingers." It has been recognized as a clinical sign for centuries and is often associated with chronic hypoxia.
Pathophysiology
The exact mechanism of clubbing is not fully understood, but it is believed to involve increased blood flow to the distal phalanges and changes in connective tissue. The following factors are thought to contribute:
- Increased vascular endothelial growth factor (VEGF)
- Platelet-derived growth factor (PDGF)
- Changes in the levels of prostaglandins
Causes
Clubbing can be associated with a variety of conditions, including:
Pulmonary Causes
Cardiac Causes
Gastrointestinal Causes
Other Causes
Clinical Features
Clubbing is characterized by:
- Softening of the nail bed
- Increased convexity of the nail
- Thickening of the distal finger (drumstick appearance)
- Loss of the normal angle between the nail and the nail bed
Diagnosis
Diagnosis of clubbing is primarily clinical. The following methods can be used to assess clubbing:
- Schamroth's window test: Absence of a diamond-shaped window when the dorsal surfaces of the distal phalanges of corresponding fingers are opposed.
- Profile sign: Increased angle between the nail and the nail bed when viewed from the side.
Management
Management of clubbing involves addressing the underlying cause. There is no specific treatment for clubbing itself. Identifying and treating the underlying condition can sometimes lead to improvement in clubbing.
See Also
References
- Schamroth, L. (1976). "Personal experience. Finger clubbing as a diagnostic sign." South African Medical Journal, 50(8), 297-300.
- Spicknall, K. E., Zirwas, M. J., & English, J. C. (2005). "Nail dystrophies: pathogenesis and management." American Journal of Clinical Dermatology, 6(1), 1-16.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends ✔ Tele visits available with certain limitations Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian